Cargando…

Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies

Detalles Bibliográficos
Autores principales:	Kater, Arnon P., Tonino, Sanne H., Spiering, Marjolein, Chamuleau, Martine E. D., Liu, Roberto, Adewoye, Adeboye Henry, Gao, Jie, Dreiling, Lyndah, Xin, Yan, Doorduijn, Jeanette K., Kersten, Marie José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809482/ https://www.ncbi.nlm.nih.gov/pubmed/29434192 http://dx.doi.org/10.1038/s41408-018-0055-x

Ejemplares similares

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
por: Hofland, Tom, et al.
Publicado: (2019)

Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma
por: van Bruggen, Jaco A. C., et al.
Publicado: (2020)

Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers 2020, 12, 3837
por: van Bruggen, Jaco A. C., et al.
Publicado: (2021)

circSLC41A1 Resists Porcine Granulosa Cell Apoptosis and Follicular Atresia by Promoting SRSF1 through miR-9820-5p Sponging
por: Wang, Huiming, et al.
Publicado: (2022)

Conditional relative survival among patients with chronic lymphocytic leukaemia: A population‐based study in the Netherlands
por: van der Straten, Lina, et al.
Publicado: (2021)

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes
por: Gabrilove, Janice, et al.
Publicado: (2008)

Nonamer dependent RAG cleavage at CpGs can explain mechanism of chromosomal translocations associated to lymphoid cancers
por: Paranjape, Amita M., et al.
Publicado: (2022)

Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Controlled Trial
por: Zelenetz, Andrew D., et al.
Publicado: (2017)

Population pharmacokinetic analysis of phase 1 bemarituzumab data to support phase 2 gastroesophageal adenocarcinoma FIGHT trial
por: Xiang, Hong, et al.
Publicado: (2020)

Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling
por: Hofland, Tom, et al.
Publicado: (2019)

HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma
por: Stevens, Wendy B.C., et al.
Publicado: (2020)

Behind the scenes of GS: preventing and curing - the GS-SE group
por: CERN, GS-SE
Publicado: (2013)

γ/δ Cells in Fetal, Neonatal, and Adult Rat Lymphoid Organs
por: Kühnlein, P., et al.
Publicado: (1995)

Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells
por: Ruvolo, Vivian R., et al.
Publicado: (2010)

Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019
por: van der Straten, Lina, et al.
Publicado: (2023)

GS BBQ 2015
por: Rueda, Laura
Publicado: (2015)

Pion photoproduction and the "anomalous" transition $^{14}$N$_{g.s.}$ --> $^{14}$C$_{g.s.}$
por: Figureau, A, et al.
Publicado: (1980)

Behind the scenes of GS: preventing and curing - the GS-SE group (VERSION FR)
por: CERN, GS-SE
Publicado: (2013)

Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018
por: van der Straten, Lina, et al.
Publicado: (2022)

Functional Differences Between EBV- and CMV-Specific CD8(+) T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL
por: Hofland, Tom, et al.
Publicado: (2020)

The 5Gs of family business
por: Vieira, Walter, et al.
Publicado: (2018)

CpGs relieve arthritis
por: Bashyam, Hema
Publicado: (2007)

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
por: Amirian, E. Susan, et al.
Publicado: (2020)

PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors
por: Yahiaoui, Anella, et al.
Publicado: (2017)

FlaGs and webFlaGs: discovering novel biology through the analysis of gene neighbourhood conservation
por: Saha, Chayan Kumar, et al.
Publicado: (2020)

COLLABORATION AGREEMENT No. KE2294/GS
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2014)

COLLABORATION AGREEMENT KE2280/GS
por: THE NATIONAL RESEARCH NUCLEAR UNIVERSITY MEPhI, RUSSIA, et al.
Publicado: (2013)

Collaboration Agreement KE2173/GS
por: The European Organization for Nuclear Research, CERN, et al.
Publicado: (2013)

COLLABORATION AGREEMENT KE2062/GS
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2012)

COLLABORATION AGREEMENT KE2067/GS
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2012)

COLLABORATION AGREEMENT KE2078/GS
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2012)

COLLABORATION AGREEMENT KE2095/GS
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2012)

Behind the scenes of GS: cross-platform
por: Katarina Anthony
Publicado: (2014)

Behind the scenes of GS: health in the workplace
por: CERN Bulletin
Publicado: (2014)

Behind the scenes of GS: Open Sesame!
por: Anaïs Schaeffer
Publicado: (2014)

COLLABORATION AGREEMENT No. KE2343/GS
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2014)

Behind the scenes of GS: Sweet dreams!
por: Anaïs Schaeffer
Publicado: (2014)

Behind the scenes of GS: the impact of IMPACT
por: Katarina Anthony
Publicado: (2014)

Behind the scenes of GS: an eye for accuracy
por: Anaïs Schaeffer
Publicado: (2014)

5Gs for crop genetic improvement
por: Varshney, Rajeev K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_labbnetue6muh05e4q28rn5cg1